CD8A and pancreatic neoplasm: Another study published in Advanced Science in 2023 has indicated that tumor-intrinsic Setd2 deficiency enhances recruitment and reprogramming of neutrophils in pancreatic tumors, thereby escaping from immune surveillance via inhibiting the cytotoxicity of CD8+ T cells42.